Clinical trials: Teriflunomide
Teriflunomide Elimination, Healthy Volunteers
Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
Primary Objective To determine if colestipol hydrochloride tablets can accelerate the elimination of teriflunomide. Teriflunomide will be administered for 14 days followed by colestipol dosing of 11 days.
- Trial name
- TERCOL (NCT02263547)
- Testing
- teriflunomide, Colestipol
- Where
- United States
- Volunteers
- 14 people, healthy volunteers welcome
- Sponsor
- Derrick Scott Robertson